Kyriakou DS - Search Results

1

The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma.

Alexandrakis MG, Passam FH, Ganotakis ES, Sfiridaki K, Xilouri I, Perisinakis K, Kyriakou DS. Alexandrakis MG, et al. Among authors: kyriakou ds. Clin Lab Haematol. 2003 Feb;25(1):41-6. doi: 10.1046/j.1365-2257.2003.00492.x. Clin Lab Haematol. 2003. PMID: 12542441

2

Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.

Katodritou E, Kyrtsonis MC, Delimpasi S, Kyriakou D, Symeonidis A, Spanoudakis E, Vasilopoulos G, Anagnostopoulos A, Kioumi A, Zikos P, Aktypi A, Briasoulis E, Megalakaki A, Repousis P, Adamopoulos I, Gogos D, Kotsopoulou M, Pappa V, Papadaki E, Fotiou D, Nikolaou E, Giannopoulou E, Hatzimichael E, Giannakoulas N, Douka V, Kokoviadou K, Timotheatou D, Terpos E. Katodritou E, et al. Ann Hematol. 2018 Sep;97(9):1671-1682. doi: 10.1007/s00277-018-3361-2. Epub 2018 May 13. Ann Hematol. 2018. PMID: 29756171 Free PMC article.

3

Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance.

Passam FH, Tsirakis G, Boula A, Fragou A, Consolas I, Alegakis A, Kyriakou DS, Alexandrakis MG. Passam FH, et al. Among authors: kyriakou ds. Clin Lab Haematol. 2004 Dec;26(6):391-5. doi: 10.1111/j.1365-2257.2004.00640.x. Clin Lab Haematol. 2004. PMID: 15595996

4

The assessment of proliferating cell nuclear antigen immunostaining in myelodysplastic syndromes and its prognostic significance.

Alexandrakis MG, Passam FH, Dambaki K, Passam AM, Nalbanti F, Stathopoulos ES, Kyriakou DS. Alexandrakis MG, et al. Among authors: kyriakou ds. Eur J Histochem. 2005 Jan-Mar;49(1):27-32. doi: 10.4081/923. Eur J Histochem. 2005. PMID: 15823791 Clinical Trial.

5

Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density.

Alexandrakis MG, Passam FH, Pappa CA, Damilakis J, Tsirakis G, Kandidaki E, Passam AM, Stathopoulos EN, Kyriakou DS. Alexandrakis MG, et al. Among authors: kyriakou ds. Int J Immunopathol Pharmacol. 2005 Apr-Jun;18(2):287-95. doi: 10.1177/039463200501800211. Int J Immunopathol Pharmacol. 2005. PMID: 15888251 Free article.

6

Urinary N-telopeptide levels in multiple myeloma patients, correlation with Tc-99m-sestaMIBI scintigraphy and other biochemical markers of disease activity.

Alexandrakis MG, Kyriakou DS, Passam FH, Malliaraki N, Vlachonikolis IG, Karkavitsas N. Alexandrakis MG, et al. Among authors: kyriakou ds. Hematol Oncol. 2003 Mar;21(1):17-24. doi: 10.1002/hon.700. Hematol Oncol. 2003. PMID: 12605419

7

Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma.

Fragioudaki M, Tsirakis G, Pappa CA, Aristeidou I, Tsioutis C, Alegakis A, Kyriakou DS, Stathopoulos EN, Alexandrakis MG. Fragioudaki M, et al. Among authors: kyriakou ds. Leuk Res. 2012 Aug;36(8):1004-8. doi: 10.1016/j.leukres.2012.03.012. Epub 2012 Apr 10. Leuk Res. 2012. PMID: 22498341

8

Serum levels of leptin in multiple myeloma patients and its relation to angiogenic and inflammatory cytokines.

Alexandrakis MG, Passam FH, Sfiridaki A, Pappa CA, Moschandrea JA, Kandidakis E, Tsirakis G, Kyriakou DS. Alexandrakis MG, et al. Among authors: kyriakou ds. Int J Biol Markers. 2004 Jan-Mar;19(1):52-7. doi: 10.5301/jbm.2008.510. Int J Biol Markers. 2004. PMID: 15077927

9

Expression of proliferating cell nuclear antigen (PCNA) in multiple myeloma: its relationship to bone marrow microvessel density and other factors of disease activity.

Alexandrakis MG, Passam FH, Pappa CA, Dambaki C, Sfakiotaki G, Alegakis AK, Kyriakou DS, Stathopoulos E. Alexandrakis MG, et al. Among authors: kyriakou ds. Int J Immunopathol Pharmacol. 2004 Jan-Apr;17(1):49-56. doi: 10.1177/039463200401700107. Int J Immunopathol Pharmacol. 2004. PMID: 15000866

10

Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival.

Alexandrakis MG, Passam FH, Sfiridaki K, Moschandrea J, Pappa C, Liapi D, Petreli E, Roussou P, Kyriakou DS. Alexandrakis MG, et al. Among authors: kyriakou ds. Leuk Res. 2004 Mar;28(3):259-66. doi: 10.1016/s0145-2126(03)00261-3. Leuk Res. 2004. PMID: 14687621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results